Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-25-156914
Filing Date
2025-07-09
Accepted
2025-07-09 10:11:07
Documents
13
Period of Report
2025-07-09

Document Format Files

Seq Description Document Type Size
1 6-K d911459d6k.htm 6-K 13689
2 EX-99.1 d911459dex991.htm EX-99.1 26724
3 EX-99.2 d911459dex992.htm EX-99.2 26527
4 EX-99.3 d911459dex993.htm EX-99.3 26723
5 EX-99.4 d911459dex994.htm EX-99.4 26590
6 EX-99.5 d911459dex995.htm EX-99.5 26730
7 EX-99.6 d911459dex996.htm EX-99.6 26527
8 EX-99.7 d911459dex997.htm EX-99.7 26716
9 EX-99.8 d911459dex998.htm EX-99.8 26716
10 EX-99.9 d911459dex999.htm EX-99.9 26896
11 EX-99.10 d911459dex9910.htm EX-99.10 26047
12 EX-99.11 d911459dex9911.htm EX-99.11 26720
13 EX-99.12 d911459dex9912.htm EX-99.12 26950
  Complete submission text file 0001193125-25-156914.txt   334612
Mailing Address 2015 PEEL STREET 5TH FLOOR MONTREAL A8 H3A 1T8
Business Address 2015 PEEL STREET 5TH FLOOR MONTREAL A8 H3A 1T8 514-336-7800
Theratechnologies Inc. (Filer) CIK: 0001512717 (see all company filings)

EIN.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1130
Type: 6-K | Act: 34 | File No.: 001-35203 | Film No.: 251112506
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)